RECURSION PHARMACEUTICALS, INC. - Class A Common Stock (RXRX)
CUSIP: 75629V104
Q1 2026 13F Holders as of 31 Mar 2026
- Type / Class
- Equity / Class A Common Stock
- Shares outstanding
- 514,715,255
- Total 13F shares
- 777,633
- Share change
- +73,931
- Total reported value
- $2,413,878
- Price per share
- $3.07
- Number of holders
- 25
- Value change
- +$210,923
- Number of buys
- 14
- Number of sells
- 9
Quarterly Holders Quick Answers
What is CUSIP 75629V104?
CUSIP 75629V104 identifies RXRX - RECURSION PHARMACEUTICALS, INC. - Class A Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
- Previous quarter: Q4 2025
Recent filing periods for CUSIP 75629V104:
Top shareholders of RXRX - RECURSION PHARMACEUTICALS, INC. - Class A Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| VANGUARD GROUP INC |
13F
|
Company |
9.2%
|
47,187,759
|
$192,997,934 | — | 31 Dec 2025 | |
| BlackRock, Inc. |
13F
13D/G
|
Company |
6.1%
from 13D/G
|
38,866,779
|
$158,965,127 | — | 31 Dec 2025 | |
| ARK Investment Management LLC |
13D/G
13F
|
Company |
7.2%
|
37,316,856
|
$152,625,941 | +$20,329,177 | 31 Dec 2025 | |
| Lux Ventures IV, L.P. |
3/4/5
|
Former 10% Owner |
—
class O/S missing
|
13,021,519
|
$137,710,376 | — | 07 Dec 2021 | |
| Mubadala Investment Co PJSC |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
12,985,927
|
$137,333,970 | — | 02 Mar 2023 | |
| STATE STREET CORP |
13F
|
Company |
4.9%
|
25,333,888
|
$103,615,602 | — | 31 Dec 2025 | |
| BAILLIE GIFFORD & CO |
13D/G
13F
|
Company |
4.6%
|
23,774,972
|
$97,239,635 | $0 | 31 Dec 2025 | |
| SOFTBANK GROUP CORP. |
13F
|
Company |
2.6%
|
13,636,515
|
$55,773,346 | — | 31 Dec 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.1%
|
10,934,252
|
$44,731,450 | — | 31 Dec 2025 | |
| RA CAPITAL MANAGEMENT, L.P. |
13D/G
|
— |
2%
|
7,725,096
|
$44,187,549 | $0 | 31 Dec 2024 | |
| Zachary Bogue |
3/4/5
|
Director, 10%+ Owner |
—
class O/S missing
|
3,736,341
|
$39,514,048 | — | 03 Jul 2023 | |
| MIC Capital Management UK LLP |
13F
|
Company |
1.9%
|
9,644,032
|
$39,444,095 | — | 31 Dec 2025 | |
| Sumitomo Mitsui Trust Group, Inc. |
13F
|
Company |
1.2%
|
6,221,025
|
$25,443,992 | — | 31 Dec 2025 | |
| Amova Asset Management Americas, Inc. |
13F
|
Company |
1.2%
|
6,221,025
|
$25,381,782 | — | 31 Dec 2025 | |
| Data Collective IV GP, LLC |
13F
|
Company |
1.2%
|
5,941,120
|
$24,299,181 | — | 31 Dec 2025 | |
| NORGES BANK |
13F
|
Company |
1.1%
|
5,739,064
|
$23,472,772 | — | 31 Dec 2025 | |
| MORGAN STANLEY |
13F
|
Company |
1.1%
|
5,657,578
|
$23,139,501 | — | 31 Dec 2025 | |
| Lingotto Investment Management LLP |
13F
|
Company |
0.96%
|
4,931,057
|
$20,168,023 | — | 31 Dec 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.85%
|
4,396,104
|
$17,980,065 | — | 31 Dec 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.82%
|
4,229,999
|
$17,300,696 | — | 31 Dec 2025 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.79%
|
4,075,219
|
$16,667,644 | — | 31 Dec 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.78%
|
3,994,651
|
$16,338,123 | — | 31 Dec 2025 | |
| DCVC Opportunity Fund II GP, LLC |
13F
|
Company |
0.77%
|
3,951,141
|
$16,160,167 | — | 31 Dec 2025 | |
| UBS Group AG |
13F
|
Company |
0.72%
|
3,692,022
|
$15,100,371 | — | 31 Dec 2025 | |
| MIC Capital Partners (Public) Parallel Cayman, LP |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
1,388,889
|
$14,688,335 | — | 01 Nov 2021 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.67%
|
3,439,949
|
$14,069,391 | — | 31 Dec 2025 | |
| FMR LLC |
13F
|
Company |
0.63%
|
3,241,892
|
$13,259,340 | — | 31 Dec 2025 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.6%
|
3,075,123
|
$12,577,253 | — | 31 Dec 2025 | |
| IQ EQ FUND MANAGEMENT (IRELAND) Ltd |
13F
|
Company |
0.47%
|
2,404,118
|
$9,832,843 | — | 31 Dec 2025 | |
| FIRST TRUST ADVISORS LP |
13F
|
Company |
0.44%
|
2,266,691
|
$9,270,766 | — | 31 Dec 2025 | |
| Michael Secora |
3/4/5
|
Chief Financial Officer |
—
mixed-class rows
|
1,836,074
mixed-class rows
|
$9,186,510 | — | 15 Nov 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.43%
|
2,201,442
|
$9,003,898 | — | 31 Dec 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.41%
|
2,112,345
|
$8,639,491 | — | 31 Dec 2025 | |
| Najat Khan |
3/4/5
|
CEO and President, Director |
—
mixed-class rows
|
3,256,029
mixed-class rows
|
$7,566,900 | -$845,425 | 09 Mar 2026 | |
| CAPITAL FUND MANAGEMENT S.A. |
13F
|
Company |
0.35%
|
1,778,976
|
$7,276,011 | — | 31 Dec 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.29%
|
1,495,839
|
$6,117,982 | — | 31 Dec 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0.29%
|
1,469,262
|
$6,009,282 | — | 31 Dec 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.25%
|
1,278,944
|
$5,230,882 | — | 31 Dec 2025 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.23%
|
1,160,990
|
$4,748,449 | — | 31 Dec 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.22%
|
1,131,583
|
$4,628,176 | — | 31 Dec 2025 | |
| Nuveen, LLC |
13F
|
Company |
0.21%
|
1,084,925
|
$4,437,344 | — | 31 Dec 2025 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.21%
|
1,084,198
|
$4,434,370 | — | 31 Dec 2025 | |
| Rafferty Asset Management, LLC |
13F
|
Company |
0.19%
|
968,814
|
$3,962,449 | — | 31 Dec 2025 | |
| Comprehensive Financial Management LLC |
13F
|
Company |
0.18%
|
941,895
|
$3,852,351 | — | 31 Dec 2025 | |
| David Hallett |
3/4/5
|
Chief Scientific Officer |
0.21%
|
1,097,151
|
$3,829,056 | — | 17 Feb 2026 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.17%
|
887,004
|
$3,627,846 | — | 31 Dec 2025 | |
| NATIONAL BANK OF CANADA /FI/ |
13F
|
Company |
0.17%
|
875,574
|
$3,581,082 | — | 31 Dec 2025 | |
| HSBC HOLDINGS PLC |
13F
|
Company |
0.16%
|
818,316
|
$3,367,371 | — | 31 Dec 2025 | |
| BNP Paribas Asset Management Holding S.A. |
13F
|
Company |
0.16%
|
799,078
|
$3,269,000 | — | 31 Dec 2025 | |
| Tina Marriott |
3/4/5
|
President and COO |
—
mixed-class rows
|
954,769
mixed-class rows
|
$3,129,811 | — | 15 Nov 2024 |
Institutional Holders of RECURSION PHARMACEUTICALS, INC. - Class A Common Stock (RXRX) as of Q1 2026
As of 31 Mar 2026,
RECURSION PHARMACEUTICALS, INC. - Class A Common Stock (RXRX) was held by
25 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
777,633 shares.
The largest 10 holders included
SG Americas Securities, LLC, Green Alpha Advisors, LLC, E Fund Management Co., Ltd., Plancorp, LLC, Values First Advisors, Inc., Accel Wealth Management, WEALTH ENHANCEMENT ADVISORY SERVICES, LLC, AssuredPartners Investment Advisors, LLC, Wedmont Private Capital, and CoreCap Advisors, LLC.
This page lists
25
institutional shareholders reporting positions in this security
for the Q1 2026 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2026 vs Q4 2025 Across Filers
Q4 2025 holders
330
Q1 2026 holders
25
Holder diff
-305
| Investor | Q4 2025 Shares | Q1 2026 Shares | Share Diff | Share Chg % | Q4 2025 Value $ | Q1 2026 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.